BCAX — BICARA THERAPEUT

Ownership history in MARSHALL WACE, LLP  ·  3 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in BICARA THERAPEUT (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 112,086 +60,277 +116.3% 0.00% $1.8M $15.79
2025 Q2 REDUCED 51,809 -15,924 -23.5% 0.00% $481K $9.29
2024 Q4 INITIATED 67,733 — — 0.00% $1.2M $17.42
% of Fund (quarterly)    BCAX price (monthly, adj. close)

Other funds also holding BCAX

As of 2025 Q4 — sorted by position size

Omega Fund Management, LLC 3Y 7Y 12.95% ACORN CAPITAL ADVISORS, LLC 3.67% Siren, L.L.C. 2.62% Vestal Point Capital, LP 2.05% Aisling Capital Management LP 3Y 7Y 2.0% TPG GP A, LLC 3Y 1.89% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.2% DAFNA Capital Management LLC 3Y 7Y 1.02% Deep Track Capital, LP 3Y 0.78% Palo Alto Investors LP 3Y 7Y 0.7%
← Back to MARSHALL WACE, LLP Holdings